Authors:
VALLES J
SANTOS MT
AZNAR J
OSA A
LAGO A
COSIN J
SANCHEZ E
BROEKMAN MJ
MARCUS AJ
Citation: J. Valles et al., ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY DECREASES THE EFFECTIVENESS OF ASPIRIN AS AN ANTITHROMBOTIC THERAPEUTIC MODALITY - RESPONSE, Circulation, 98(17), 1998, pp. 1826-1827
Authors:
VALLES J
SANTOS MT
AZNAR J
OSA A
LAGO A
COSIN J
SANCHEZ E
BROEKMAN MJ
MARCUS AJ
Citation: J. Valles et al., ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY DECREASES THE EFFECTIVENESS OF ASPIRIN AS AN ANTITHROMBOTIC THERAPEUTIC MODALITY - THE EFFECT OF LOW-DOSE ASPIRIN IS LESS-THAN OPTIMAL IN PATIENTS WITH VASCULAR-DISEASE DUE TO PROTHROMBOTIC EFFECTS OF ERYTHROCYTES ON PLATELET REACTIVITY, Circulation, 97(4), 1998, pp. 350-355
Authors:
VALLES J
SANTOS MT
AZNAR J
LAGO A
OSO A
COSIN J
MOSCARDO A
Citation: J. Valles et al., ERYTHROCYTE PROMOTION OF PLATELET REACTIVITY REDUCES THE EFFECTIVENESS OF ASPIRIN IN PATIENTS WITH VASCULAR-DISEASE, Thrombosis and haemostasis, 1997, pp. 1877-1877
Authors:
ELLENS H
EDDY EP
LEE CP
DOUGHERTY P
LAGO A
XIANG JN
ELLIOTT JD
CHENG HY
OHLSTEIN E
SMITH PL
Citation: H. Ellens et al., IN-VITRO PERMEABILITY SCREENING FOR IDENTIFICATION OF ORALLY BIOAVAILABLE ENDOTHELIN RECEPTOR ANTAGONISTS, Advanced drug delivery reviews, 23(1-3), 1997, pp. 99-109
Authors:
MILLER W
KEENAN R
ALI F
BONDINELL W
BURGESS J
CALLAHAN J
CALVO R
COUSINS R
GOWEN M
HUFFMAN W
HWANG S
JAKAS D
KU T
KWON C
LAGO A
NGUYEN T
READER V
ROSS S
SAMANEN J
SOUTHALL L
TAKATA D
UZINSKAS I
VENSLAVSKY J
WONG A
YELLIN T
YUAN C
Citation: W. Miller et al., NONPEPTIDE VITRONECTIN RECEPTOR ANTAGONISTS, Journal of bone and mineral research, 11, 1996, pp. 429-429
Citation: Pl. Shkolnikov et al., PHASE-MATCHING OPTIMIZATION OF LARGE-SCALE NONLINEAR FREQUENCY UP-CONVERSION IN NEUTRAL AND IONIZED-GASES, Journal of the Optical Society of America. B, Optical physics, 13(2), 1996, pp. 412-423
Authors:
OHLSTEIN EH
NAMBI P
LAGO A
HAY DWP
BECK G
FONG KL
EDDY EP
SMITH P
ELLENS H
ELLIOTT JD
Citation: Eh. Ohlstein et al., NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONISTS .6. PHARMACOLOGICAL CHARACTERIZATION OF SE-217242, A POTENT AND HIGHLY BIOAVAILABLE ENDOTHELIN RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 276(2), 1996, pp. 609-615
Citation: Pl. Shkolnikov et al., OPTIMAL QUASI-PHASE-MATCHING FOR HIGH-ORDER HARMONIC-GENERATION IN GASES AND PLASMA, Physical review. A, 50(6), 1994, pp. 180004461-180004464
Authors:
VILCHEZ JJ
LAGO A
BURGUERA JA
YAYA R
CASANOVA V
Citation: Jj. Vilchez et al., CHLORMETHIAZOLE IN THE MANAGEMENT OF THE OPSOCLONUS-MYOCLONUS SYNDROME, Journal of international medical research, 22(1), 1994, pp. 55-62
Citation: Pl. Shkolnikov et al., PHASE-MATCHING FOR LARGE-SCALE FREQUENCY UP-CONVERSION IN PLASMA (VOL18, PG 1700, 1993), Optics letters, 19(10), 1994, pp. 764-764
Citation: Pl. Shkolnikov et al., PHASE-MATCHING OPTIMA FOR HIGH-ORDER MULTIWAVE MIXING AND HARMONIC-GENERATION BEYOND PERTURBATION LIMIT, Optics communications, 111(1-2), 1994, pp. 93-98
Authors:
OHLSTEIN EH
NAMBI P
DOUGLAS SA
EDWARDS RM
GELLAI M
LAGO A
LEBER JD
COUSINS RD
GAO AM
FRAZEE JS
PEISHOFF CE
BEAN JW
EGGLESTON DS
ELSHOURBAGY NA
KUMAR C
LEE JA
YUE TL
LOUDEN C
BROOKS DP
WEINSTOCK J
FEUERSTEIN G
POSTE G
RUFFOLO RR
GLEASON JG
ELLIOTT JD
Citation: Eh. Ohlstein et al., SB-209670, A RATIONALLY DESIGNED POTENT NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST, Proceedings of the National Academy of Sciences of the United Statesof America, 91(17), 1994, pp. 8052-8056